Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Muggia

Showing results (401-410 of 424) with videos related to

Pageof 43
Sort By:
Plos One|January 26, 2010
A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanomaPatrick A Ott, Anne Hamilton, Amanda Jones, et al.
Gynecologic Oncology|May 1, 1997
Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot studyL I Muderspach, J P Curtin, L D Roman, et al.
Cancer|January 22, 2009
The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group studyKristin K Zorn, Chunqiao Tian, William P McGuire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group studyC G Leichman, T R Fleming, F M Muggia, et al.
Hematology/Oncology Clinics of North America|September 10, 2003
Intraperitoneal therapy as consolidation for patients with ovarian cancer and negative reassessment after platinum-based chemotherapyM Janice Lu, Joan Sorich, Maitreyee Hazarika, et al.
Cancer Research|May 1, 1988
Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferonM D Green, J L Speyer, H S Hochster, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
The disposition of carboplatin in ovarian cancer patientsR C Gaver, N Colombo, M D Green, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trialM Hayat, G Brulé, P Cappelaere, et al.
Psycho-Oncology|August 29, 2000
Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trialC M Moinpour, J Sawyers Triplett, B McKnight, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2012
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysisBradley J Monk, Thomas J Herzog, Stanley B Kaye, et al.
Pageof 43

Showing results (401-410 of 424) with videos related to

Sort By:
Pageof 43
Plos One|January 26, 2010
A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanomaPatrick A Ott, Anne Hamilton, Amanda Jones, et al.
Gynecologic Oncology|May 1, 1997
Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot studyL I Muderspach, J P Curtin, L D Roman, et al.
Cancer|January 22, 2009
The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group studyKristin K Zorn, Chunqiao Tian, William P McGuire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group studyC G Leichman, T R Fleming, F M Muggia, et al.
Hematology/Oncology Clinics of North America|September 10, 2003
Intraperitoneal therapy as consolidation for patients with ovarian cancer and negative reassessment after platinum-based chemotherapyM Janice Lu, Joan Sorich, Maitreyee Hazarika, et al.
Cancer Research|May 1, 1988
Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferonM D Green, J L Speyer, H S Hochster, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
The disposition of carboplatin in ovarian cancer patientsR C Gaver, N Colombo, M D Green, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trialM Hayat, G Brulé, P Cappelaere, et al.
Psycho-Oncology|August 29, 2000
Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trialC M Moinpour, J Sawyers Triplett, B McKnight, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2012
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysisBradley J Monk, Thomas J Herzog, Stanley B Kaye, et al.
Pageof 43